Ginkgo Bioworks Holdings Inc vs Kyndryl Holdings Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Kyndryl Holdings Inc trades at $13.26 (market cap $2.91B). The key difference: Kyndryl Holdings Inc is far larger — about 5.8× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.
| DNA | KD | |
|---|---|---|
Market Cap | $505.73M | $2.91B |
Sector | Health | Technology |
52-Week High | $16.14 | $33.14 |
52-Week Low | $5.48 | $10.59 |
Enterprise Value | $607.68M | $5.74B |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →